EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma

Stephanie C Y Yu, Jiaen Deng, Rong Qiao, Suk Hang Cheng, Wenlei Peng, So Ling Lau, L Y Lois Choy iD, Tak Y Leung, John Wong, Vincent Wai-Sun Wong iD, Grace L H Wong, Peiyong Jiang iD und 3 weitere

Clinical Chemistry · 2023

DOI: 10.1093/clinchem/hvac180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2023. Verfasst von Stephanie C Y Yu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Novostics, Hong Kong Science Park, Pak Shek Kok, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Nanopore Sequencing, Cell-Free Nucleic Acids, Liver Neoplasms. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation and Technology Commission, Li Ka Shing Foundation, Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent studies using single molecule, real-time (SMRT) sequencing revealed a substantial population of analyzable long cell-free DNA (cfDNA) in plasma. Potential clinical utilities of such long cfDNA in pregnancy and cancer have been demonstrated. However, the performance of different long-read sequencing platforms for the analysis of long cfDNA remains unknown.

Methods

Size biases of SMRT sequencing by Pacific Biosciences (PacBio) and nanopore sequencing by Oxford Nanopore Technologies (ONT) were evaluated using artificial mixtures of sonicated human and mouse DNA of different sizes. cfDNA from plasma samples of pregnant women at different trimesters, hepatitis B carriers, and patients with hepatocellular carcinoma were sequenced with the 2 platforms.

Results

Both platforms showed biases to sequence longer (1500 bp vs 200 bp) DNA fragments, with PacBio showing a stronger bias (5-fold overrepresentation of long fragments vs 2-fold in ONT). Percentages of cfDNA fragments 500 bp were around 6-fold higher in PacBio compared with ONT. End motif profiles of cfDNA from PacBio and ONT were similar, yet exhibited platform-dependent patterns. Tissue-of-origin analysis based on single-molecule methylation patterns showed comparable performance on both platforms.

Conclusions

SMRT sequencing generated data with higher percentages of long cfDNA compared with nanopore sequencing. Yet, a higher number of long cfDNA fragments eligible for the tissue-of-origin analysis could be obtained from nanopore sequencing due to its much higher throughput. When analyzing the size and end motif of cfDNA, one should be aware of the analytical characteristics and possible biases of the sequencing platforms being used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nanopore SequencingCell-Free Nucleic AcidsLiver NeoplasmsHumansFemalePregnancyAnimalsMiceHigh-Throughput Nucleotide SequencingSequence Analysis, DNADNA

Stichwörter der Autor:innen

cancer detectionliquid biopsynoninvasive prenatal testingsingle-molecule sequencingthird-generation sequencing

Substanzen

Cell-Free Nucleic AcidsDNA

Autor:innen und Institutionen

  • Centre for Novostics, Hong Kong Science Park, Pak Shek Kok, Hong Kong SAR, China.
  • Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  • Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.

ORCID-Profile: L Y Lois Choy, Vincent Wai-Sun Wong, Peiyong Jiang, K C Allen Chan

Förderung

  • Innovation and Technology Commission
  • Li Ka Shing Foundation
  • Gilead Sciences

Zitieren

APA

Yu, S. C. Y., Deng, J., Qiao, R., Cheng, S. H., Peng, W., Lau, S. L., Choy, L. Y. L., Leung, T. Y., Wong, J., Wong, V. W., Wong, G. L. H., Jiang, P., Chiu, R. W. K., Chan, K. C. A., & Lo, Y. M. D. (2023). Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvac180

Vancouver

Yu SCY, Deng J, Qiao R, Cheng SH, Peng W, Lau SL, et al. Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma. Clinical Chemistry. 2023. doi:10.1093/clinchem/hvac180

BibTeX
@article{Yu2023,
  author = {Yu, Stephanie C Y and Deng, Jiaen and Qiao, Rong and Cheng, Suk Hang and Peng, Wenlei and Lau, So Ling and Choy, L Y Lois and Leung, Tak Y and Wong, John and Wong, Vincent Wai-Sun and Wong, Grace L H and Jiang, Peiyong and Chiu, Rossa W K and Chan, K C Allen and Lo, Y M Dennis},
  title = {Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma},
  journal = {Clinical Chemistry},
  year = {2023},
  doi = {10.1093/clinchem/hvac180}
}
Kostenlos starten →